Keywords: Study characteristics; Multivariate meta-analysis; Acamprosate; Naltrexone; Alcohol treatment research;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Naltrexone; Acamprosate; Alcohol dependence; Pharmacotherapy; Prescription;
Keywords: Acamprosate; Pharmacokinetics; Bioequivalence; LC-MS/MS;
Keywords: Chronic care management; Substance abuse treatment; Medications; Naltrexone; Acamprosate; Buprenorphine
Keywords: ANOVA; analysis of variance; GABA; γ-aminobutyric acid; SEM; standard error of the mean; NMDA; N-methyl-d-aspartate; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; iGluRs; ionotropic glutamate receptors; mGluRs; metabotropic glutamate recep
Keywords: Acamprosate; Alcohol use disorder; Medicaid; Insurance; Health reform; Affordable Care Act
Keywords: Ethanol; Multiple schedules; DHEA; Pregnanolone; Naltrexone; Acamprosate
Impact of acamprosate on plasma amyloid-β precursor protein in youth: A pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker
Keywords: Amyloid precursor protein; Autism spectrum disorder; Acamprosate; Glutamate; Biomarker; GABA;
Modeling longitudinal drinking data in clinical trials: An application to the COMBINE study
Keywords: Clinical trial; Alcoholism; Naltrexone; Acamprosate; Cognitive behavioral intervention; Zero inflation; Poisson hurdle model;
Quantification of Acamprosate in human plasma by LC-ESI-MS/MS with solid phase extraction: Application to a bioequivalence study
Keywords: Acamprosate; Human plasma; LC-ESI-MS/MS; Pharmacokinetics; Pharmacokinetic study;
Neuropharmacology and analgesiaAcamprosate {monocalcium bis(3-acetamidopropane-1-sulfonate)} reduces ethanol-drinking behavior in rats and glutamate-induced toxicity in ethanol-exposed primary rat cortical neuronal cultures
Keywords: Acamprosate; Glutamate signals; Alcohol dependence; Ethanol; N-Methyl-d-aspartate receptor; Voltage-gated calcium channels; Metabotropic glutamate receptor subtype 5;
Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response
Keywords: Medication adherence; Compliance; Naltrexone; Acamprosate; Therapy; Side effects
Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test
Keywords: CDPPB; 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl) benzamide; NMDA; N-Methyl-d-aspartic acid; Acamprosate; CDPPB; mGlu5 receptor; NMDA; Tail suspension test;
Cigarette Smoking Predicts Differential Benefit from Naltrexone for Alcohol Dependence
Keywords: Acamprosate; alcohol dependence; behavioral treatment; cigarette smoking; naltrexone; pharmacotherapy;
Influence of ionization source design on matrix effects during LC–ESI-MS/MS analysis
Keywords: LC–MS/MS; Matrix effect; Acamprosate; Phospholipids; Orthogonal spray; Z-Spray; Ion source design
Cocaine reverses the naltrexone-induced reduction in operant ethanol self-administration: The effects on immediate-early gene expression in the rat prefrontal cortex
Keywords: Naltrexone; Acamprosate; Prefrontal; C-fos; COX-2; Genetic expression;
Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1
Keywords: Acamprosate; ENT1; Ethanol withdrawal; [1H] MRS; GABA; Glutamate
Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment
Keywords: Trajectory-based analysis; Clinical trial; Baseline predictors; Naltrexone; Acamprosate; Combined behavioral intervention
A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence
Keywords: Acamprosate; Cocaine; Clinical trial; Placebo;
Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1
Keywords: Alcoholism; ENT1; Glutamate; Taurine; In vivo MRS; Acamprosate
The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: A randomized controlled trial
Keywords: Alcohol dependence; Anti-craving medication; Behavioural therapy; Acamprosate;
Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation
Keywords: Medication-assisted treatment; Disulfiram; Tablet naltrexone; Acamprosate; Buprenorphine; Injectable naltrexone
Medicare prescription drug plan coverage of pharmacotherapies for opioid and alcohol dependence in WA
Keywords: Medicare policy; Buprenorphine; Methadone; Naltrexone; Acamprosate; Disulfiram
How cognitive assessment through clinical neurophysiology may help optimize chronic alcoholism treatment
Keywords: Cognitive neuropsychiatry; ERPs; Alcohol dependence; Naltrexone; AcamprosateNeuropsychiatrie cognitive; ERPs; Alcoolisme; Naltrexone; Acamprosate
The adoption of alcohol pharmacotherapies in the Clinical Trials Network: The influence of research network participation
Keywords: Tablet naltrexone; Acamprosate; Research networks; Adoption of innovations; Clinical Trials Network
Effect of early and late compliance on the effectiveness of acamprosate in the treatment of alcohol dependence
Keywords: Compliance; Acamprosate; Alcohol dependence; IPD meta-analysis
Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study
Keywords: Alcohol research; Naltrexone; Acamprosate; Combined behavioral intervention; Clinical trial; Trajectory-based analysis
The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin
Keywords: Alcohol dependence; Treatment; Acamprosate; Craving; Neuroendocrine; HPA
Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty
Keywords: Alcoholism; Opioid dependence; Acamprosate; Buprenorphine; Disulfiram; Naltrexone;
Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence
Keywords: Acamprosate; Alcoholism; Detoxification; Clinical trial; Placebo
Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in Swiss Webster mice
Keywords: Acamprosate; Alcohol; Withdrawal; Mice; Convulsion; Swiss Webster
The effect of acamprosate on alcohol and food craving in patients with alcohol dependence
Keywords: Acamprosate; Craving; Food; Body mass index
Effect of chronic acamprosate treatment on voluntary alcohol intake and β-endorphin plasma levels in rats selectively bred for high alcohol preference
Keywords: Acamprosate; Alcohol-preferring rats; β-Endorphin; Free-choice procedure; Ethanol withdrawal;
Use of Anti-Craving Agents in Soldiers with Alcohol Dependence Syndrome
Keywords: Topiramate; Naltrexone; Acamprosate; Alcohol dependence syndrome
The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats
Keywords: Ethanol withdrawal; Anxiety; Elevated plus-maze; Memantine; Acamprosate; MTEP; EMQMCM; NMDA; mGlu receptor; Behavior
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Keywords: Alcohol dependence; Pharmacotherapy; Naltrexone; Acamprosate; Ondansetron; Topiramate
Influence of age at drinking onset on the alcohol deprivation effect and stress-induced drinking in female rats
Keywords: Long-term alcohol self-administration; Alcohol deprivation effect (ADE); Swim stress; Foot-shock stress; Rats; Adolescence; Acamprosate
The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics
Keywords: Alcoholism; Naltrexone; Acamprosate; Efficacy; Craving; Cue reactivity
Effects of treatment with acamprosate on β-endorphin plasma concentration in humans with high alcohol preference
Keywords: Acamprosate; β-Endorphin; Alcohol;
Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: The role of patient motivation
Keywords: Acamprosate; Alcohol dependence; Alcoholism; Manual-guided therapy; Pharmacotherapy; Relapse prevention
Changes in the beta-endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference
Keywords: Acamprosate; Alcohol preferring rats; β-Endorphin;
Tinnitus treatment with acamprosate: double-blind study
Keywords: tinnitus; acamprosate;
Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism
Keywords: Craving; Naltrexone; Acamprosate; Leptin; Addiction; Alcohol;
Production of reactive oxygen species following acute ethanol or acetaldehyde and its reduction by acamprosate in chronically alcoholized rats
Keywords: Reactive oxygen species; Acute ethanol; Acetaldehyde; Acamprosate; Microdialysis;
Recent advances in the treatment of alcoholism
Keywords: Alcoholism; Pharmacotherapy; Treatment; Medication adherence; Naltrexone; Acamprosate;
Acamprosate for the treatment of alcohol dependence
Keywords: acamprosate; Campral; calcium aminotaurine; alcohol dependence; alcoholism;